Effects of MDMA and Methylphenidate on Social Cognition
Brief Summary
The purpose of this study is to assess and compare the effects of a single dose of 3,4-methylenedioxymethamphetamine (MDMA)and methylphenidate (MPH) on emotional and social cognition in healthy subjects. The investigators hypothesize that MDMA enhances affective perception for positive and impairs perception for negative emotional stimuli compared to placebo or MPH.
Intervention / Treatment
-
Drug: 3,4-methylenedioxymethamphetamine
-
Drug: Methylphenidate
-
Drug: Placebo
Condition or Disease
- Social Cognition
Phase
Study Design
| Study type: | Interventional |
|---|---|
| Status: | Completed |
| Study results: | No Results Available |
| Age: | 18 Years to 45 Years (Adult) |
| Enrollment: | 30 () |
| Funded by: | Other |
Masking |
|
Clinical Trial Dates
| Start date: | Aug 01, 2012 | |
|---|---|---|
| Primary Completion: | Dec 01, 2012 | |
| Completion Date: | Apr 01, 2013 | |
| Study First Posted: | Jun 11, 2012 | |
| Results First Posted: | Aug 30, 2020 | |
| Last Updated: | Dec 11, 2018 |
Sponsors / Collaborators
Lead Sponsor:
N/A
Responsible Party:
N/A
Location
Eligibility Criteria
| Sex: | All |
|---|---|
| Minimum Age: | 18 |
| Maximum Age: | 45 |
More Details
| NCT Number: | NCT01616407 |
|---|---|
| Other IDs: | EK 382/11|2012DR1018 |
| Study URL: | https://ClinicalTrials.gov/show/NCT01616407 |
Last updated: Jun 17, 2022